Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development

Molecular and Cellular Biology

Volumn 27, Issue 16, 2007, Pages 5849-5859

  Greig, Kylie T ^a,b   Antonchuk, Jennifer ^a   Metcalf, Donald ^a   Morgan, Phillip O ^a   Krebs, Danielle L ^a   Zhang, Jian Guo ^a   Hacking, Douglas F ^a   Bode, Lars ^c   Robb, Lorraine ^a   Kranz, Christian ^c   De Graaf, Carolyn ^a,b   Bahlo, Melanie ^a   Nicola, Nicos A ^a   Nutt, Stephen L ^a   Freeze, Hudson H ^c   Alexander, Warren S ^a   Hilton, Douglas J ^a   Kile, Benjamin T ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOSYLPHOSPHATIDYLINOSITOL; HEXOSAMINE; MESSENGER RNA; N ACETYLGLUCOSAMINE; PHOSPHOGLUCOMUTASE; PHOSPHOGLUCOMUTASE 3; PROTEIN AGM1; PROTEIN PGM3; SUGAR NUCLEOTIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ALLELE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CATALYSIS; CELL TYPE; CONTROLLED STUDY; CYTOARCHITECTURE; ENZYME ACTIVITY; FEMALE; GENE; HEMATOPOIESIS; LEUKOPENIA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS CELL; PGM3 GENE; PHENOTYPE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; THROMBOCYTOPENIA;

ALLELES; ANIMALS; BASE SEQUENCE; EMBRYONIC DEVELOPMENT; FEMALE; GLYCOSYLATION; HEMATOPOIESIS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTATION; PANCREAS; PHOSPHOGLUCOMUTASE; RNA SPLICING; SALIVARY GLANDS; SPERMATOGENESIS; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE;

ANIMALIA; MUS;

EID: 34547913040     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00802-07     Document Type: Article

References (34)

1. Alexander, W. S., D. Metcalf, and A. R. Dunn. 1995. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 14:5569-5578.
2. Alexander, W. S., A. W. Roberts, N. A. Nicola, R. Li, and D. Metcalf. 1996. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87:2162-2170.
3. Ault, K. A., and C. Knowles. 1995. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp. Hematol. 23:996-1001.
4. Bigge, J. C., T. P. Patel, J. A. Bruce, P. N. Goulding, S. M. Charles, and R. B. Parekh. 1995. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 230:229-238.
5. Bode, L., and H. H. Freeze. 2006. Applied glycoproteomics - approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim. Biophys. Acta 1760:547-559.
6. Bode, L., S. Murch, and H. H. Freeze. 2006. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J. Biol. Chem. 281:7809-7815.
7. Bode, V. C. 1984. Ethylnitrosourea mutagenesis and the isolation of mutant alleles for specific genes located in the T region of mouse chromosome 17. Genetics 108:457-470.
8. Boehmelt, G., A. Wakeham, A. Elia, T. Sasaki, S. Plyte, J. Potter, Y. Yang, E. Tsang, J. Ruland, N. N. Iscove, J. W. Dennis, and T. W. Mak. 2000. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J. 19:5092-5104.
9. Boles, E., W. Liebetrau, M. Hofmann, and F. K. Zimmermann. 1994. A family of hexosephosphate mutases in Saccharomyces cerevisiae. Eur. J. Biochem. 220:83-96.
10. Dietrich, W., H. Katz, S. E. Lincoln, H. S. Shin, J. Friedman, N. C. Dracopoli, and E. S. Lander. 1992. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423-447.
11. Reference deleted.
12. Esther, C. R., Jr., T. E. Howard, E. M. Marino, J. M. Goddard, M. R. Capecchi, and K. E. Bernstein. 1996. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab. Investig. 74:953-965.
13. Hagaman, J. R., J. S. Moyer, E. S. Bachman, M. Sibony, P. L. Magyar, J. E. Welch, O. Smithies, J. H. Krege, and D. A. O'Brien. 1998. Angiotensin-converting enzyme and male fertility. Proc. Natl. Acad. Sci. USA 95:2552-2557.
14. Hansen, J., T. Floss, P. Van Sloun, E.-M. Fuechtbauer, F. Vauti, H.-H. Arnold, F. Schnütgen, W. Wurst, H. von Melchner, and P. Ruiz. 2003. A large scale, gene-driven mutagenesis approach for the functional analysis of the mouse genome. Proc. Natl. Acad. Sci. USA 100:9918-9922.
15. Hassoun, H., T. Hanada, M. Lutchman, K. E. Sahr, J. Palek, M. Hanspal, and A. H. Chishti. 1998. Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood 91:2146-2151.
16. Hofmann, M., E. Boles, and F. K. Zimmermann. 1994. Characterization of the essential yeast gene encoding N-acetylglucosamine- phosphate mutase. Eur. J. Biochem. 221:741-747.
17. Hopkinson, D. A., and H. Harris. 1968. A third phosphoglucomutase locus in man. Ann. Hum. Genet. 31:359-367.
18. Hurst, D., C. M. Rylett, R. E. Isaac, and A. D. Shirras. 2003. The Drosophila angiotensin-converting enzyme homologue Ance is required for spermiogenesis. Dev. Biol. 254:238-247.
19. Krebs, D., R. Uren, D. Metcalf, S. Rakar, J. Zhang, R. Starr, D. De Souza, K. Hanzinikolas, J. Eyles, L. Connolly, R. Simpson, N. Nicola, S. Nicholson, M. Baca, D. Hilton, and W. Alexander. 2002. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell. Biol. 22:4567-4578.
20. Krege, J. H., S. W. John, L. L. Langenbach, J. B. Hodgin, J. R. Hagaman, E. S. Bachman, J. C. Jennette, D. A. O'Brien, and O. Smithies. 1995. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148.
21. Kreppel, L. K., and G. W. Hart. 1999. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274:32015-32022.
22. Li, C., M. Rodriguez, and D. Banerjee. 2000. Cloning and characterization of complementary DNA encoding human N-acetylglucosamine- phosphate mutase protein. Gene 242:97-103.
23. Lowe, J. B., and J. D. Marth. 2003. A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72:643-691.
24. Mio, T., T. Yamada-Okabe, M. Arisawa, and H. Yamada-Okabe. 2000. Functional cloning and mutational analysis of the human cDNA for phosphoacetylglucosamine mutase: identification of the amino acid residues essential for the catalysis. Biochim. Biophys. Acta 1492:369-376.
25. Moritz, R. L., J. S. Eddes, G. E. Reid, and R. J. Simpson. 1996. S-Pyridylethylation of intact polyacrylamide gels and in situ digestion of electrophoretically separated proteins: a rapid mass spectrometric method for identifying cysteine-containing peptides. Electrophoresis 17:907-917.
26. Moritz, R. L., and R. J. Simpson. 1992. Application of capillary reversed-phase high-performance liquid chromatography to high-sensitivity protein sequence analysis. J. Chromatogr. 599:119-130.
27. Pang, H., Y. Koda, M. Soejima, and H. Kimura. 2002. Identification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1). Ann. Hum. Genet. 66:139-144.
28. Shaft, R., S. P. Iyer, L. G. Ellies, N. O'Donnell, K. W. Marek, D. Chui, G. W. Hart, and J. D. Marth. 2000. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. USA 97:5735-5739.
29. Shi, S., S. A. Williams, A. Seppo, H. Kurniawan, W. Chen, Z. Ye, J. D. Marth, and P. Stanley. 2004. Inactivation of the Mgat1 gene in oocytes impairs oogenesis, but embryos lacking complex and hybrid N-glycans develop and implant. Mol. Cell. Biol. 24:9920-9929.
30. Span, P. 2001. Assays for hexosamine pathway intermediates (uridine diphosphate-N-acetyl amino sugars) in small samples of human muscle tissue. Clin. Chem. 47:944-946.
31. Wang, Y., J. Tan, M. Sutton-Smith, D. Ditto, M. Panico, R. M. Campbell, N. M. Varki, J. M. Long, J. Jaeken, S. R. Levinson, A. Wynshaw-Boris, H. R. Morris, D. Le, A. Dell, H. Schachter, and J. D. Marth. 2001. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11:1051-1070.
32. Wells, L., and G. W. Hart. 2003. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett. 546:154-158.
33. Xia, L., T. Ju, A. Westmuckett, G. An, L. Ivanciu, J. M. McDaniel, F. Lupu, R. D. Cummings, and R. P. McEver. 2004. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J. Cell Biol. 164:451-459.
34. Yu, X. C., E. D. Sturrock, Z. Wu, K. Biemann, M. R. Ehlers, and J. F. Riordan. 1997. Identification of N-linked glycosylation sites in human testis angiotensin-converting enzyme and expression of an active deglycosylated form. J. Biol. Chem. 272:3511-3519.